xanthenes has been researched along with Depression in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (33.33) | 18.7374 |
| 1990's | 12 (33.33) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, S; Lee, JA; Lee, JG; Park, SW; Seo, MK; Seog, DH | 1 |
| Fujiwara, T; Miyanishi, H; Miyazaki, T; Muramatsu, SI; Nitta, A; Sodeyama, K; Uno, K | 1 |
| Pałucha-Poniewiera, A; Podkowa, K; Rafało-Ulińska, A | 1 |
| Jing, XY; Li, LF; Li, ZL; Liu, YJ; Wang, Y; Zou, HW | 1 |
| Pałucha-Poniewiera, A; Pilc, A; Podkowa, K | 1 |
| Chaki, S; Iijima, M; Koike, H | 2 |
| Chaki, S; Koike, H | 1 |
| Filipek, B; Gałuszka, A; Kazek, G; Kij, A; Marona, H; Olczyk, A; Pytka, K; Rapacz, A; Sapa, J; Siwek, A; Walczak, M; Waszkielewicz, A | 1 |
| Chaki, S; Fukumoto, K; Iijima, M | 1 |
| Brański, P; Pałucha-Poniewiera, A; Pilc, A; Pochwat, B; Podkowa, K | 1 |
| Bespalov, AY; Gross, G; Mezler, M; Schoemaker, H; Sukhotina, IA; van Gaalen, MM; Wicke, K | 1 |
| Hübner, WD; Lande, S; Podzuweit, H | 1 |
| Hänsgen, KD; Ploch, M; Vesper, J | 1 |
| Arnoldt, KH; Hübner, WD; Vorbach, EU | 1 |
| Harrer, G; Hübner, WD; Podzuweit, H | 1 |
| Burkard, G; Grünwald, J; Woelk, H | 1 |
| Brink, I; Ploch, M; Thiele, B | 1 |
| Harrer, G; Sommer, H | 1 |
| Wheatley, D | 1 |
| Hafner, U; Müller, WE; Rolli, M; Schäfer, C | 1 |
| Nierenberg, A | 1 |
| Miller, AL | 1 |
| Brasseur, R | 1 |
| Ciurezu, T; Predescu, V; Roman, I; Timofte, G | 1 |
| Coleman, J; Hall, P | 1 |
| Ban, TA; Lehmann, HE; Oliveros, RT; Saxena, BM; Sterlin, C | 1 |
| Imboden, JB; Park, LC | 1 |
| Nikolovski, OT; Simeon, J; Spero, M | 1 |
| Medvecká, E; Medvecký, J; Safko, S | 1 |
| Amin, M; Angus, JW; Edwards, JG; Go, SH; Lee, JH; Simpson, GM | 1 |
| Cermak, I; Ringel, R | 1 |
| Poeldinger, W | 1 |
| Mariategui, J; Raab, ES | 1 |
2 review(s) available for xanthenes and Depression
| Article | Year |
|---|---|
St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.
Topics: Depression; Depressive Disorder; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
Clinical and heuristic value of clinical drug research.
Topics: Affective Symptoms; Amitriptyline; Amphetamine; Butyrophenones; Child Behavior Disorders; Chlorpromazine; Clinical Trials as Topic; Depression; Humans; Imipramine; Neurotic Disorders; Phenothiazines; Piperazines; Placebos; Psychopharmacology; Psychotherapy; Research; Schizophrenia; Sulfides; Tranquilizing Agents; Xanthenes | 1970 |
14 trial(s) available for xanthenes and Depression
| Article | Year |
|---|---|
Hypericum treatment of mild depressions with somatic symptoms.
Topics: Adult; Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Perylene; Plant Extracts; Plants, Medicinal; Psychometrics; Quercetin; Xanthenes | 1994 |
Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Perylene; Plant Extracts; Plants, Medicinal; Psychometrics; Quercetin; Self-Assessment; Xanthenes | 1994 |
Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.
Topics: Adult; Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Hypericum; Imipramine; Male; Middle Aged; Perylene; Plant Extracts; Plants, Medicinal; Psychometrics; Quercetin; Severity of Illness Index; Xanthenes | 1994 |
Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study.
Topics: Adult; Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Maprotiline; Middle Aged; Perylene; Plant Extracts; Plants, Medicinal; Psychometrics; Quercetin; Severity of Illness Index; Treatment Outcome; Xanthenes | 1994 |
Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Drug Monitoring; Female; Humans; Hypericum; Male; Middle Aged; Patient Dropouts; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Risk Factors; Treatment Outcome; Xanthenes | 1994 |
Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients.
Topics: Adult; Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1994 |
LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Outpatients; Perylene; Plants, Medicinal; Psychiatric Status Rating Scales; Quercetin; Xanthenes | 1997 |
[Value of Déanxit in the ambulatory treatment of depressive states. Clinical study of 205 cases].
Topics: Adult; Aged; Ambulatory Care; Anthracenes; Anxiety Disorders; Clinical Trials as Topic; Depression; Drug Combinations; Female; Humans; Male; Middle Aged; Outpatient Clinics, Hospital; Piperazines; Tranquilizing Agents; Xanthenes | 1972 |
Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.
Topics: Adult; Age Factors; Ambulatory Care; Anxiety; Clinical Trials as Topic; Depression; Drug Tolerance; Ethanol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Neurotic Disorders; Pain; Piperazines; Placebos; Sex Factors; Syndrome; Tranquilizing Agents; Xanthenes | 1973 |
Thiothixene. Its range of therapeutic activity.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle Aged; Neurotic Disorders; Psychiatric Status Rating Scales; Schizophrenia; Thiothixene; Xanthenes | 1970 |
Clinical and heuristic value of clinical drug research.
Topics: Affective Symptoms; Amitriptyline; Amphetamine; Butyrophenones; Child Behavior Disorders; Chlorpromazine; Clinical Trials as Topic; Depression; Humans; Imipramine; Neurotic Disorders; Phenothiazines; Piperazines; Placebos; Psychopharmacology; Psychotherapy; Research; Schizophrenia; Sulfides; Tranquilizing Agents; Xanthenes | 1970 |
Psychopharmacology.
Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chronic Disease; Clinical Trials as Topic; Depression; Ethanol; Humans; Injections, Intramuscular; Meprobamate; Phenothiazines; Piperazines; Propranolol; Psychopharmacology; Reserpine; Retinitis; Schizophrenia; Thioridazine; Trifluoperazine; Xanthenes | 1970 |
Thiothixene in the treatment of anxiety and depression in outpatients.
Topics: Adult; Anxiety; Depression; Female; Humans; Male; Middle Aged; Placebos; Procyclidine; Xanthenes | 1970 |
Role of antidepressants and neuroleptics in the treatment of depression.
Topics: Adult; Amitriptyline; Chronic Disease; Depression; Female; Humans; Imipramine; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Thiothixene; Tranquilizing Agents; Xanthenes | 1972 |
21 other study(ies) available for xanthenes and Depression
| Article | Year |
|---|---|
Effects of Chronic LY341495 on Hippocampal mTORC1 Signaling in Mice with Chronic Unpredictable Stress-Induced Depression.
Topics: Amino Acids; Animals; Antidepressive Agents; Depression; Hippocampus; Mechanistic Target of Rapamycin Complex 1; Mice; Stress, Psychological; Xanthenes | 2022 |
Vulnerability to depressive behavior induced by overexpression of striatal Shati/Nat8l via the serotonergic neuronal pathway in mice.
Topics: Acetyltransferases; Amino Acids; Animals; Brain; Causality; Corpus Striatum; Depression; Fluvoxamine; Male; Mice; Mice, Inbred C57BL; Serotonergic Neurons; Stress, Psychological; Xanthenes | 2019 |
The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Topics: Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Male; Mice; Mice, Inbred C57BL; Motor Skills; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Synaptosomes; Xanthenes | 2021 |
mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.
Topics: Amino Acids; Animals; Depression; Disease Models, Animal; Humans; Male; Mice; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Resilience, Psychological; Social Defeat; Stress, Psychological; Xanthenes | 2021 |
Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
Topics: Amino Acids; Animals; Antidepressive Agents; Azepines; Benzamides; Depression; Depressive Disorder; Excitatory Amino Acid Antagonists; Ketamine; Male; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, AMPA; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2019 |
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Excitatory Amino Acid Antagonists; Immobility Response, Tonic; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Swimming; Xanthenes | 2013 |
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Topics: Adaptation, Psychological; Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ketamine; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Stress, Psychological; Swimming; Time Factors; Xanthenes | 2014 |
The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rotarod Performance Test; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Swimming; Xanthenes; Xanthones | 2015 |
The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
Topics: Amino Acids; Animals; Antidepressive Agents; Depression; Dorsal Raphe Nucleus; Fenclonine; Ketamine; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Prefrontal Cortex; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Serotonergic Neurons; Xanthenes | 2016 |
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
Topics: Amino Acids; Animals; Antidepressive Agents; Behavior, Animal; Blotting, Western; Depression; Drug Synergism; Excitatory Amino Acid Antagonists; Ketamine; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Swimming; TOR Serine-Threonine Kinases; Xanthenes | 2016 |
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Darkness; Depression; Diazepam; Fever; Fluoxetine; Light; Male; Mice; Paroxetine; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Stress, Psychological; Xanthenes | 2008 |
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Topics: Amino Acids; Analysis of Variance; Animals; Bridged Bicyclo Compounds; Depression; Dicarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred ICR; Receptors, Metabotropic Glutamate; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Xanthenes | 2011 |
Modulation of cytokine expression by hypericum extract.
Topics: Antidepressive Agents; Cytokines; Depression; Humans; Hypericum; In Vitro Techniques; Interleukin-1; Interleukin-6; Perylene; Pilot Projects; Plant Extracts; Plants, Medicinal; Quercetin; Tumor Necrosis Factor-alpha; Xanthenes | 1994 |
Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain; Depression; Dopamine Uptake Inhibitors; Female; Hypericum; Imipramine; Mice; Monoamine Oxidase; Perylene; Plants, Medicinal; Prefrontal Cortex; Quercetin; Rats; Receptors, Adrenergic, beta; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Synaptosomes; Xanthenes | 1997 |
Should you take St. John's Wort?
Topics: Depression; Depressive Disorder; Humans; Hypericum; Perylene; Phytotherapy; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
Can you tell me about St. John's wort? I've been depressed and wonder if it would be safe to take.
Topics: Antidepressive Agents; Depression; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
Flupenthixol in the treatment of depressive states.
Topics: Adjustment Disorders; Administration, Oral; Adolescent; Adult; Aged; Depression; Ethanol; Female; Humans; Male; Middle Aged; Piperazines; Tranquilizing Agents; Xanthenes | 1973 |
Thiothixene in the treatment of paranoid psychoses.
Topics: Adult; Depression; Female; Humans; Male; Paranoid Disorders; Schizophrenia; Thiothixene; Tranquilizing Agents; Xanthenes | 1972 |
[Clinical experiences with the new psychoactivator Deanxit (Melitracen and Flupenthixol)].
Topics: Adult; Anthracenes; Antidepressive Agents; Depression; Ethanol; Female; Humans; Male; Middle Aged; Piperazines; Premenstrual Syndrome; Propylamines; Psychopharmacology; Psychophysiologic Disorders; Tranquilizing Agents; Xanthenes | 1971 |
[Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
Topics: Adult; Chlorprothixene; Clopenthixol; Depression; Female; Humans; Male; Middle Aged; Movement Disorders; Oral Manifestations; Paranoid Disorders; Parasympatholytics; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |
[Thiothixene in ambulatory treatment of emotional disorders. Preliminary evaluation].
Topics: Adult; Affective Symptoms; Ambulatory Care; Anxiety; Depression; Humans; Male; Middle Aged; Thiothixene; Tranquilizing Agents; Xanthenes | 1968 |